Isoquercetin Market Size, Share, Growth, and Industry Analysis, Types (95％-98%, ≥98％, Others), Applications (Food & Beverage, Cosmetics, Supplements, Healthcare), and Regional Insights and Forecast to 2035

Isoquercetin Market Size

The Global Isoquercetin Market size was USD 1.22 Billion in 2025 and is projected to reach USD 1.31 Billion in 2026, further growing to USD 1.41 Billion in 2027 and USD 2.55 Billion by 2035, exhibiting a CAGR of 7.66% during the forecast period. Around 40% of demand comes from supplements, while nearly 28% is driven by food and beverage applications. Cosmetics contribute about 22%, and healthcare accounts for approximately 10% of total market usage.

The US Isoquercetin Market is expanding steadily, with nearly 50% of demand coming from dietary supplements. Around 30% of usage is linked to functional food products, while cosmetics contribute approximately 20%. Consumer awareness of antioxidant benefits has increased by nearly 35%, supporting continued growth.

Key Findings

• Market Size: Valued at $1.22Bn in 2025, projected to touch $1.31Bn in 2026 to $2.55Bn by 2035 at a CAGR of 7.66%.
• Growth Drivers: 62% natural preference, 48% supplement demand, 35% awareness growth, 30% product innovation.
• Trends: 45% clean-label products, 38% high-purity focus, 33% supplement innovation, 27% functional foods growth.
• Key Players: CSNpharm, Inc., Cayman Chemical Company, Xingrui Industry Co., Limited, ChemFaces, BOCSCI Inc.
• Regional Insights: North America 36%, Europe 28%, Asia-Pacific 27%, Middle East & Africa 9% with balanced demand.
• Challenges: 34% raw material issues, 29% stability concerns, 24% processing needs, 18% consistency problems.
• Industry Impact: 40% supplement growth, 28% food demand, 22% cosmetic usage, 10% healthcare adoption.
• Recent Developments: 35% production increase, 30% purity improvement, 28% product innovation, 22% sustainability focus.

The Isoquercetin Market continues to grow as industries focus on natural ingredients, improved product quality, and expanding applications across supplements, food, and cosmetics.

Isoquercetin is widely used as a natural antioxidant and plays an important role in supporting health-focused products. Around 50% of modern supplement formulations now include flavonoids, showing the growing importance of this compound in the global health and wellness industry.

Isoquercetin Market Trends

The Isoquercetin Market is gaining steady attention as consumers shift toward plant-based ingredients and natural health solutions. Around 62% of consumers now prefer products with natural flavonoids, which is directly supporting the demand for isoquercetin. Nearly 48% of supplement manufacturers have increased the use of plant-derived compounds in their formulations, with isoquercetin being a key ingredient due to its antioxidant properties. The supplements segment alone contributes close to 40% of total demand, while food and beverage applications account for nearly 28%, driven by functional food trends. In cosmetics, isoquercetin usage has grown by approximately 22% as brands focus on natural skin protection ingredients. Healthcare applications represent around 10% of the market, with growing research supporting its benefits. Additionally, nearly 35% of manufacturers are investing in higher purity grades to improve product effectiveness. Consumer awareness regarding antioxidant benefits has increased by over 30%, further boosting adoption. The shift toward clean-label products is influencing nearly 45% of new product launches, where isoquercetin plays a key role as a natural active ingredient.

Isoquercetin Market Dynamics

OPPORTUNITY

Rising demand for natural health ingredients

The demand for natural health ingredients is creating strong opportunities in the Isoquercetin Market. Nearly 55% of consumers now prefer supplements with plant-based compounds. Around 38% of functional food manufacturers are incorporating flavonoids into their products. In addition, approximately 30% of cosmetic brands are shifting toward natural antioxidants, increasing the use of isoquercetin. These trends highlight strong growth potential across multiple industries.

DRIVERS

Increasing awareness of antioxidant benefits

Growing awareness of antioxidant benefits is a key driver in the Isoquercetin Market. Around 50% of consumers actively look for antioxidant-rich products. Nearly 42% of healthcare professionals recommend flavonoid-based supplements for preventive health. Demand in the supplements segment has increased by approximately 33%, while functional beverages have seen growth of about 27%. These factors are pushing higher adoption of isoquercetin across industries.

RESTRAINTS

"Limited availability of high-purity raw materials"

The Isoquercetin Market faces restraints due to the limited availability of high-quality raw materials. Around 34% of manufacturers report challenges in sourcing consistent plant-based extracts. Nearly 26% of production delays are linked to raw material shortages. In addition, about 20% of suppliers struggle with maintaining purity levels, which can impact product quality and market growth.

CHALLENGE

"Maintaining product stability and consistency"

Maintaining stability and consistency in isoquercetin-based products is a key challenge. Around 29% of manufacturers face issues related to shelf life and formulation stability. Nearly 24% of products require additional processing to maintain effectiveness. In addition, about 18% of companies experience variability in product performance, making standardization difficult across applications.

Segmentation Analysis

The Isoquercetin Market is segmented by type and application, with each segment contributing to overall growth. The Global Isoquercetin Market size was USD 1.22 Billion in 2025 and is projected to touch USD 1.31 Billion in 2026, further reaching USD 1.41 Billion in 2027 and USD 2.55 Billion by 2035, exhibiting a CAGR of 7.66% during the forecast period [2026-2035]. Growth is driven by increasing demand across supplements, food, and cosmetics industries.

By Type

95%-98%

This segment holds nearly 44% share and is widely used in food and beverage applications due to its cost-effectiveness. Demand has increased by approximately 28% as manufacturers focus on balancing quality and affordability in functional food products.

95%-98% Market Size, revenue in 2026 Share and CAGR for 95%-98%. This segment accounted for USD 0.58 Billion in 2026, representing 44% of the total market. This segment is expected to grow at a CAGR of 7.66% from 2026 to 2035, driven by food and beverage applications.

≥98%

The ≥98% purity segment accounts for around 38% share and is mainly used in supplements and healthcare applications. Demand has grown by nearly 32% due to increasing preference for high-purity ingredients in premium products.

≥98% Market Size, revenue in 2026 Share and CAGR for ≥98%. This segment accounted for USD 0.50 Billion in 2026, representing 38% of the total market. This segment is expected to grow at a CAGR of 7.66% from 2026 to 2035, driven by supplements and healthcare demand.

Others

Other purity grades contribute approximately 18% share and are used in niche applications, including cosmetics and research. Demand has increased by around 20% as companies explore new uses for isoquercetin in specialized products.

Others Market Size, revenue in 2026 Share and CAGR for Others. This segment accounted for USD 0.23 Billion in 2026, representing 18% of the total market. This segment is expected to grow at a CAGR of 7.66% from 2026 to 2035, driven by niche applications.

By Application

Food & Beverage

The food and beverage segment accounts for nearly 28% share, with demand increasing by over 26% due to rising interest in functional foods and natural additives. Isoquercetin is widely used to enhance nutritional value.

Food & Beverage Market Size, revenue in 2026 Share and CAGR for Food & Beverage. This segment accounted for USD 0.37 Billion in 2026, representing 28% of the total market. This segment is expected to grow at a CAGR of 7.66% from 2026 to 2035, driven by functional food demand.

Cosmetics

Cosmetics hold around 22% share, with usage increasing by approximately 24% as brands focus on natural skincare ingredients. Isoquercetin is valued for its antioxidant and skin-protective properties.

Cosmetics Market Size, revenue in 2026 Share and CAGR for Cosmetics. This segment accounted for USD 0.29 Billion in 2026, representing 22% of the total market. This segment is expected to grow at a CAGR of 7.66% from 2026 to 2035, driven by natural skincare trends.

Supplements

Supplements dominate with nearly 40% share, supported by growing health awareness. Demand has increased by approximately 35% as consumers look for natural antioxidant supplements.

Supplements Market Size, revenue in 2026 Share and CAGR for Supplements. This segment accounted for USD 0.52 Billion in 2026, representing 40% of the total market. This segment is expected to grow at a CAGR of 7.66% from 2026 to 2035, driven by rising health awareness.

Healthcare

Healthcare applications account for around 10% share, with demand growing by nearly 18% due to increasing research on flavonoid benefits in disease prevention and treatment.

Healthcare Market Size, revenue in 2026 Share and CAGR for Healthcare. This segment accounted for USD 0.13 Billion in 2026, representing 10% of the total market. This segment is expected to grow at a CAGR of 7.66% from 2026 to 2035, driven by research and clinical applications.

Isoquercetin Market Regional Outlook

The Isoquercetin Market shows steady growth across regions due to increasing demand for natural antioxidants and plant-based ingredients. The Global Isoquercetin Market size was USD 1.22 Billion in 2025 and is projected to touch USD 1.31 Billion in 2026, further reaching USD 1.41 Billion in 2027 and USD 2.55 Billion by 2035, exhibiting a CAGR of 7.66% during the forecast period. Regional demand is influenced by consumer awareness, product innovation, and availability of natural ingredients. North America and Europe lead in adoption due to strong demand for supplements and clean-label products, while Asia-Pacific is growing fast with increasing production capacity. The Middle East & Africa region is gradually expanding with rising interest in natural healthcare products.

North America

North America holds around 36% share of the Isoquercetin Market, supported by high consumer awareness and strong demand for dietary supplements. Nearly 52% of consumers in this region prefer plant-based ingredients in health products. Around 40% of supplement manufacturers include flavonoids like isoquercetin in their formulations. Demand in functional foods has grown by approximately 28%, while cosmetics applications account for about 22% of regional usage.

North America Market Size, Share and CAGR for region. North America held the largest share in the Isoquercetin Market, accounting for USD 0.47 Billion in 2026, representing 36% of the total market. This segment is expected to grow at a CAGR of 7.66% from 2026 to 2035, driven by strong demand for natural health products.

Europe

Europe accounts for nearly 28% share, driven by increasing preference for clean-label and organic products. Around 48% of consumers actively choose products with natural ingredients. The supplements segment contributes close to 38% of regional demand, while cosmetics account for about 25%. Demand for isoquercetin in functional foods has increased by approximately 26% across the region.

Europe Market Size, Share and CAGR for region. Europe accounted for USD 0.37 Billion in 2026, representing 28% of the total market. This segment is expected to grow at a CAGR of 7.66% from 2026 to 2035, driven by rising demand for organic and natural products.

Asia-Pacific

Asia-Pacific holds about 27% share and is one of the fastest-growing regions in the Isoquercetin Market. Around 45% of demand comes from food and beverage applications, supported by increasing interest in functional foods. Supplements contribute nearly 30% of regional demand. Production capacity in this region has increased by over 35%, helping to meet rising global demand.

Asia-Pacific Market Size, Share and CAGR for region. Asia-Pacific accounted for USD 0.35 Billion in 2026, representing 27% of the total market. This segment is expected to grow at a CAGR of 7.66% from 2026 to 2035, driven by manufacturing growth and rising consumer awareness.

Middle East & Africa

The Middle East & Africa region contributes around 9% share, with gradual growth supported by increasing awareness of natural health products. Around 32% of demand comes from supplements, while cosmetics account for approximately 20%. Consumer awareness has increased by nearly 18%, supporting steady adoption across the region.

Middle East & Africa Market Size, Share and CAGR for region. Middle East & Africa accounted for USD 0.12 Billion in 2026, representing 9% of the total market. This segment is expected to grow at a CAGR of 7.66% from 2026 to 2035, driven by rising health awareness.

List of Key Isoquercetin Market Companies Profiled

Investment Analysis and Opportunities in Isoquercetin Market

Investment in the Isoquercetin Market is increasing as companies focus on expanding production capacity and improving product quality. Around 42% of investments are directed toward high-purity extraction technologies, helping manufacturers meet rising demand for premium products. Nearly 36% of companies are investing in research and development to explore new applications in healthcare and cosmetics. Around 30% of investments focus on expanding production facilities in Asia-Pacific, where manufacturing costs are lower. In addition, nearly 25% of funding is directed toward product innovation, including functional foods and dietary supplements. Partnerships between ingredient suppliers and consumer brands have increased by approximately 22%, improving market reach. Emerging markets attract around 20% of investments due to growing consumer awareness. These trends highlight strong opportunities for long-term growth in the Isoquercetin Market.

New Products Development

New product development in the Isoquercetin Market is focused on improving effectiveness and expanding applications. Around 38% of new products are developed with higher purity levels to enhance performance. Nearly 33% of manufacturers are introducing isoquercetin-based supplements with improved absorption rates. About 29% of new products are designed for functional foods, including beverages and fortified snacks. In cosmetics, around 24% of new formulations include isoquercetin for its antioxidant and anti-aging benefits. Manufacturers are also focusing on sustainability, with approximately 20% of new products using eco-friendly extraction methods. In addition, around 27% of companies are developing customized formulations for specific health benefits. These innovations reflect the growing importance of isoquercetin in modern product development.

Recent Developments

• High-purity product launch: A company introduced a new isoquercetin product with over 30% improved purity levels, enhancing effectiveness in supplements and healthcare applications.
• Expansion of production capacity: Manufacturers increased output by approximately 35% to meet rising global demand for natural antioxidants and plant-based ingredients.
• New cosmetic formulations: A skincare brand launched products containing isoquercetin, improving antioxidant protection by nearly 25% and boosting product demand.
• Partnership for innovation: Companies collaborated to develop new functional food products, increasing product adoption by around 28% across health-conscious consumers.
• Focus on sustainability: A manufacturer introduced eco-friendly extraction processes, reducing waste by approximately 22% and improving production efficiency.

Report Coverage

The Isoquercetin Market report provides a comprehensive overview of industry trends, segmentation, and regional insights. Around 60% of the analysis focuses on application-based demand, highlighting the importance of isoquercetin in supplements, food, and cosmetics. Nearly 35% of the report covers technological advancements, including improvements in extraction methods and product purity. Regional analysis accounts for 100% of global market distribution, offering insights into how North America, Europe, Asia-Pacific, and the Middle East & Africa contribute to overall growth. Approximately 30% of the report focuses on competitive strategies, including product development and partnerships. Investment trends represent nearly 25% of the coverage, highlighting growth opportunities across regions. Around 20% of the report examines challenges such as raw material availability and product consistency. The report provides a balanced mix of quantitative and qualitative insights, helping stakeholders understand market dynamics and identify growth opportunities.

Isoquercetin Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1.22 Billion in 2026
Market Size Value By	USD 2.55 Billion by 2035
Growth Rate	CAGR of 7.66% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Food & Beverage Cosmetics Supplements Healthcare By Application : 95％-98% ≥98％ Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample

Frequently Asked Questions

• What value is the Isoquercetin Market expected to touch by 2035?

  The global Isoquercetin Market is expected to reach USD 2.55 Billion by 2035.

• What CAGR is the Isoquercetin Market expected to exhibit by 2035?

  The Isoquercetin Market is expected to exhibit a CAGR of 7.66% by 2035.

• Who are the top players in the Isoquercetin Market?

  Xingrui Industry Co., Limited, CSNpharm, Inc., Cayman Chemical Company, Autech Industry Co.,Limited, Baoji Herbest Bio-Tech, Xi'an Hao-Xuan Bio-Tech, Manus Aktteva Biopharma LLP, Xi'an Lyphar Biotech, Shaanxi Dideu Medichem, BOCSCI Inc, ChemFaces

• What was the value of the Isoquercetin Market in 2025?

  In 2025, the Isoquercetin Market value stood at USD 1.22 Billion.